Kai Xin San ameliorates scopolamine-induced cognitive dysfunction
Kai Xin San ameliorates scopolamine-induced cognitive dysfunction
摘要
关键词
Kai Xin San/cognitive dysfunction/scopolamine hydrobromide/neuroprotection/oxidative stress/synaptic dysfunction/apoptosis/cholinergic system dysfunction/donepezil/neural regenerationKey words
Kai Xin San/cognitive dysfunction/scopolamine hydrobromide/neuroprotection/oxidative stress/synaptic dysfunction/apoptosis/cholinergic system dysfunction/donepezil/neural regeneration分类
医药卫生引用本文复制引用
Yu-Min Xu,Yun-Bo Chen,Li Guan,Yong-Qi Fang,Shi-Jie Zhang,Qi Wang,Wei-Xiong Liang,Xin-Chen Wang,Ting-Ting Xu,Hong-Ying Li,Shang-Yan Hei,Na-Chuan Luo,Hong Wang,Wei Zhao,Shu-Huan Fang..Kai Xin San ameliorates scopolamine-induced cognitive dysfunction[J].中国神经再生研究（英文版）,2019,14(5):794-804,11.基金项目
This study was supported by the National Natural Science Foundation of China, No. 81473740, 81673627, 81673717 (to QW) （to QW）
Guangzhou Science Technology and Innovation Commission Technology Research Projects, China, No. 2018050100 (to QW) （to QW）
the Foundation for Characteristic Innovation of Educational Commission of Guangdong Province, China, Grant No. 2016KTSCX011 (to SHF) （to SHF）
the Open Tending Project for Construction of High-Level University, Guang-zhou University of Chinese Medicine, China, No. 34 and 118, 2017 (to SHF) （to SHF）
the Technology Platform of Clinical Trials on New Traditional Medicine, China, No. 2012ZX09303009-003 (to WXL) （to WXL）
the Technology Platform of Clinical Evaluation on New Traditional Medicine, China, No. 2008ZX09312-021 (to WXL). The funding sources had no role in study conception and design, data analysis or interpretation, paper writ-ing or deciding to submit this paper for publication. （to WXL）
